Copyright
©The Author(s) 2023.
World J Pharmacol. Feb 17, 2023; 12(1): 1-11
Published online Feb 17, 2023. doi: 10.5497/wjp.v12.i1.1
Published online Feb 17, 2023. doi: 10.5497/wjp.v12.i1.1
Figure 1 Itraconazole with APSGTM: Maximizing bioavailability.
Figure 2 Conventional itraconazole vs APSGTM itraconazole.
Figure 3 Flowchart of study design and subject disposition.
PK: Pharmacokinetics. *2 were the additional subjects which were replaced with the subjects withdrawn due to adverse events.
- Citation: Naqvi SMH, Gala MYN, Muchhala S, Arumugam A, Panigrahi D, Patil D, Rathod R, Mane A. Pharmacokinetics/Pharmacodynamics study of Fixtral SB as compared to supra bioavailable itraconazole and conventional itraconazole. World J Pharmacol 2023; 12(1): 1-11
- URL: https://www.wjgnet.com/2220-3192/full/v12/i1/1.htm
- DOI: https://dx.doi.org/10.5497/wjp.v12.i1.1